|
Recruiting
|
NCT05036681 -
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
|
Phase 2 |
|
Completed
|
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 |
|
Recruiting
|
NCT06192017 -
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
|
|
|
Recruiting
|
NCT05902988 -
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
|
Phase 1/Phase 2 |
|
Completed
|
NCT03899441 -
Multimedia Aid Gynecologic Counseling and Consent
|
N/A |
|
Completed
|
NCT02552121 -
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
|
Phase 1/Phase 2 |
|
Completed
|
NCT02001623 -
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
|
Phase 1/Phase 2 |
|
Completed
|
NCT02997553 -
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
|
Phase 3 |
|
Suspended
|
NCT03095664 -
Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors
|
N/A |
|
Active, not recruiting
|
NCT01466777 -
Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy
|
N/A |
|
Completed
|
NCT01068483 -
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
|
Phase 1 |
|
Recruiting
|
NCT03896113 -
Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma
|
Phase 2 |
|
Not yet recruiting
|
NCT03570866 -
PET/CT in the Management of Patients With Early Stage Endometrial Cancer
|
|
|
Completed
|
NCT05246462 -
The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients
|
N/A |
|
Withdrawn
|
NCT04464967 -
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT05651282 -
Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer
|
Phase 4 |
|
Completed
|
NCT06187558 -
Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery
|
|
|
Completed
|
NCT06312917 -
Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer
|
N/A |
|
Active, not recruiting
|
NCT03951415 -
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
|
Phase 2 |
|
Recruiting
|
NCT04212910 -
Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
|
|